1. P. G. Deryabin, D. K. Lvov, Ye. I. Isaeva, G. A. Danlybaeva, R. Ya. Podchernyaeva, and M. Yu. Shchelkanov, The spectrum of veterbrates’ cell lines sensitive to highly pathogenic influenza A/tem/SA/61 (H5N3) and A/duck/Novosibirsk/56/05 (H5N1) viruses. Vopr. Virusol., 52, No. 1, 45-47 (2007).
2. D. K. Lvov, E. I. Burtseva, G. A. Galegov, N. V. Belyakova, E. S. Shevchenko, L. V. Kolobukhina, L. N. Merkulova, A. G. Prilipov, I. A. Leneva, N. I. Baranov, V. N. Gorelikov, and D. D. Abramov, Sensitivity of the epidemic and pandemic influenza virus strains to zanamivir (RelenzeTM) in in vitro experiments. Vopr. Virusol., 55, No. 6, 10-14 (2010).
3. D. K. Lvov, M. Yu. Shchelkanov, P. G. Deryabin, T. V. Grebennikova, A. G. Prilipov, Ye. A. Nepoklonov, G. G. Onishchenko, N. A. Vlasov, T. I. Aliper, A. D. Zaberezhnyi, D. Ye. Kireyev, O. P. Krasheninnikov, S.T. Kiryukhin, Ye. I. Burtseva, and A. N. Slepushkin, Isolation of influenza A/H5N1 virus strains from poultry and wild birds in West Siberia during epizooty (July 2005) and their depositing to the state collection of viruses (August 8, 2005). Vopr. Virusol., 51, No. 1, 11-14 (2006).
4. V. A. Shibnev, T. M. Garaev, M. P. Finogenova, E. S. Shevchenko, E. I. Burtseva, Search for new drugs: Some pathways to overcoming drug resistance of influenza a virus to adamantane derivatives. Pharm. Chem. J., 46, No. 1, 1-5 (2012).
5. V. A. Shibnev, T. M. Garaev, M. P. Finogenova, E. S. Shevchenko, and E. I. Burtseva, New Adamantane Derivatives Can Overcome Resistance of Influenza A(H1N1)pdm2009 and A(H3N2) Viruses to Remantadine. Bull. Exp. Biol. Med., 153, No. 2. C. 233-235 (2012).